NCT06615167 · RECRUITING
Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders
This trial is testing ALZGUARD, a smartphone app designed to help detect major neurocognitive disorders including dementia. Researchers want to know whether the app's assessments match the diagnostic conclusions of medical doctors, and whether the app is safe to use. This is a Phase NA confirmatory trial — meaning it is focused on validating performance of an already-developed diagnostic tool, not testing a drug.
You may qualify if
- Participants must be between 55 and 85 years old (both men and women).
- Participants must be able to understand and voluntarily agree to the purpose, content, and procedures of the clinical trial.
You're excluded if
- Participants with no literacy or illiteracy.
- Participants with an intellectual disability.
- Participants with presenting active psychiatric symptoms.
- Participants who have difficulty ALZGUARD application
- Participants who are unable to use a smartphone, unless they can use it with assistant.
- Participants with a history of suicidal ideation or suicidal complusion in the last 6 months.
- Other conditions as deemed inappropriate for study participant by the Principal Investigator(PI).
The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.
Eligibility criteria as of 2024-09-26